The FTC report said the companies responsible for controlling spending on drugs were sometimes steering patients toward more expensive medicines.
Related Posts
Novo Nordisk New Pill Reduces Heart Attacks, Strokes in Diabetic Patients
The Wegovy maker’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up […]
Korea Zinc Gets Sweetened Takeover Offer
A consortium led by South Korean private-equity firm MBK Partners has raised its offer for Korea Zinc, sending shares of the world’s largest refined zinc […]
23andMe Lays Off 40% of Staff, Shuts Drug Development Business
The genetics company is closing a unit that was once seen as core to its future.